Literature DB >> 1536740

Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma.

M M Fitzpatrick1, V Shah, G Filler, M J Dillon, T M Barratt.   

Abstract

There is evidence of neutrophil involvement in the pathogenesis of the haemolytic uraemic syndrome (HUS), and neutrophil release products are thought to cause endothelial cell damage. Elastase is the major lysosomal proteinase liberated by activated neutrophils. In this study we measured both free and complexed elastase. No free elastase activity could be detected in the plasma of patients with diarrhoea-associated (D+) HUS using a specific substrate. However, there was a marked increase in alpha 1-antitrypsin (alpha 1-AT) complexed elastase as measured by a newly developed enzyme-linked immunosorbent assay not only in D+ HUS, but also in non-diarrhoea-associated (D-) HUS. This finding is independent of either a high polymorphonuclear leucocyte count or renal failure. This increase in bound elastase together with our sequential data which demonstrate raised alpha 1-AT complexed elastase levels early in the disease process further support the theory that neutrophil activation is one of the key events in the pathophysiology of this disorder.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1536740     DOI: 10.1007/bf00856833

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  28 in total

1.  Neutrophil elastases and haemolytic uraemic syndrome.

Authors:  D Milford; C M Taylor; F Rafaat; E Halloran; J Dawes
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

Review 2.  alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage.

Authors:  R W Carrell
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

Review 3.  Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.

Authors:  P M Henson; R B Johnston
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

4.  Haemolytic uraemic syndrome.

Authors:  M Levin; J M Barratt
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

5.  Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome.

Authors:  K D Forsyth; A C Simpson; M M Fitzpatrick; T M Barratt; R J Levinsky
Journal:  Lancet       Date:  1989-08-19       Impact factor: 79.321

6.  Changes in the postenteropathic form of the hemolytic uremic syndrome in children.

Authors:  N A Coad; T Marshall; B Rowe; C M Taylor
Journal:  Clin Nephrol       Date:  1991-01       Impact factor: 0.975

7.  Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase.

Authors:  L A Smedly; M G Tonnesen; R A Sandhaus; C Haslett; L A Guthrie; R B Johnston; P M Henson; G S Worthen
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

8.  Plasma inhibitor of glomerular fibrinolysis in the hemolytic-uremic syndrome.

Authors:  J M Bergstein; U Kuederli; N U Bang
Journal:  Am J Med       Date:  1982-09       Impact factor: 4.965

9.  Alpha-1-antitrypsin-human leukocyte elastase complexes in blood: quantification by an enzyme-linked differential antibody immunosorbent assay and comparison with alpha-2-plasmin inhibitor-plasmin complexes.

Authors:  M S Brower; P C Harpel
Journal:  Blood       Date:  1983-05       Impact factor: 22.113

10.  The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo.

Authors:  R J Johnson; W G Couser; C E Alpers; M Vissers; M Schulze; S J Klebanoff
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  21 in total

1.  CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation.

Authors:  James K Roche; Tiffany R Keepers; Lisa K Gross; Regina M Seaner; Tom G Obrig
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 2.  Leukocytosis as a predictor for progression to haemolytic uraemic syndrome in Escherichia coli O157:H7 infection.

Authors:  M A Anjay; P Anoop; A Britland
Journal:  Arch Dis Child       Date:  2007-09       Impact factor: 3.791

Review 3.  Advances in haemolytic uraemic syndrome.

Authors:  C M Taylor; L A Monnens
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

4.  Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration.

Authors:  B P Hurley; C M Thorpe; D W Acheson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Induction of Neutrophil Extracellular Traps in Shiga Toxin-Associated Hemolytic Uremic Syndrome.

Authors:  Maria Victoria Ramos; Maria Pilar Mejias; Florencia Sabbione; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Maria Marta Amaral; Ramon Exeni; Analia Silvina Trevani; Marina Sandra Palermo
Journal:  J Innate Immun       Date:  2016-05-28       Impact factor: 7.349

6.  Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia.

Authors:  G C Fernandez; M F Lopez; S A Gomez; M V Ramos; L V Bentancor; R J Fernandez-Brando; V I Landoni; G I Dran; R Meiss; M A Isturiz; M S Palermo
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

7.  Verotoxin activates mitogen-activated protein kinase in human peripheral blood monocytes: role in apoptosis and proinflammatory cytokine release.

Authors:  Pamela Cameron; Susan J Smith; Mark A Giembycz; Dino Rotondo; Robin Plevin
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

8.  Role of the transient receptor potential vanilloid type 1 channel in renal inflammation induced by lipopolysaccharide in mice.

Authors:  Youping Wang; Donna H Wang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-11-14       Impact factor: 3.619

9.  Elevated levels of vascular endothelial growth factor in serum of patients with D+ HUS.

Authors:  D Maroeska Te Loo; Nienke Bosma; Victor Van Hinsbergh; Paul Span; Rob De Waal; Ruud Clarijs; C Sweep; Leo Monnens; Lambertus Van Den Heuvel
Journal:  Pediatr Nephrol       Date:  2004-05-13       Impact factor: 3.714

10.  Soluble circulating cell adhesion molecules in haemolytic uraemic syndrome.

Authors:  C D Inward; A A Pall; D Adu; D V Milford; C M Taylor
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.